APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA

被引:63
作者
Russell, Rebecca A. [1 ]
Moore, Michael D. [2 ]
Hu, Wei-Shau [2 ]
Pathak, Vinay K. [1 ]
机构
[1] NCI, Viral Mutat Sect, HIV Drug Resistance Program, Ctr Canc Res, Frederick, MD 21702 USA
[2] NCI, Viral Recombinat Sect, HIV Drug Resistance Program, Ctr Canc Res, Frederick, MD 21702 USA
来源
RETROVIROLOGY | 2009年 / 6卷
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; VIF PROTEIN; CYTIDINE DEAMINATION; IN-VIVO; NUCLEOPROTEIN COMPLEXES; INFECTIVITY FACTOR; ENZYME APOBEC3G; DEGRADATION; CELLS;
D O I
10.1186/1742-4690-6-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Naturally occurring Vif variants that are unable to inhibit the host restriction factor APOBEC3G (A3G) have been isolated from infected individuals. A3G can potentially induce G-to-A hypermutation in these viruses, and hypermutation could contribute to genetic variation in HIV-1 populations through recombination between hypermutant and wild-type genomes. Thus, hypermutation could contribute to the generation of immune escape and drug resistant variants, but the genetic contribution of hypermutation to the viral evolutionary potential is poorly understood. In addition, the mechanisms by which these viruses persist in the host despite the presence of A3G remain unknown. Results: To address these questions, we generated a replication-competent HIV-1 Vif mutant in which the A3G-binding residues of Vif, (YRHHY44)-R-40, were substituted with five alanines. As expected, the mutant was severely defective in an A3G-expressing T cell line and exhibited a significant delay in replication kinetics. Analysis of viral DNA showed the expected high level of G-to-A hypermutation; however, we found substantially reduced levels of G-to-A hypermutation in intracellular viral RNA ( cRNA), and the levels of G-to-A mutations in virion RNA (vRNA) were even further reduced. The frequencies of hypermutation in DNA, cRNA, and vRNA were 0.73%, 0.12%, and 0.05% of the nucleotides sequenced, indicating a gradient of hypermutation. Additionally, genomes containing start codon mutations and early termination codons within gag were isolated from the vRNA. Conclusion: These results suggest that sublethal levels of hypermutation coupled with purifying selection at multiple steps during the early phase of viral replication lead to the packaging of largely unmutated genomes, providing a mechanism by which mutant Vif variants can persist in infected individuals. The persistence of genomes containing mutated gag genes despite this selection pressure indicates that dual infection and complementation can result in the packaging of hypermutated genomes which, through recombination with wild-type genomes, could increase viral genetic variation and contribute to evolution.
引用
收藏
页数:15
相关论文
共 49 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo [J].
Beale, RCL ;
Petersen-Mahrt, SK ;
Watt, IN ;
Harris, RS ;
Rada, C ;
Neuberger, MS .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (03) :585-596
[3]   Antiviral potency of APOBEC proteins does not correlate with cytidine deamination [J].
Bishop, Kate N. ;
Holmes, Rebecca K. ;
Malim, Michael H. .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8450-8458
[4]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[5]   A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor [J].
Bogerd, HP ;
Doehle, BP ;
Wiegand, HL ;
Cullen, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3770-3774
[6]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[7]   The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G [J].
Conticello, SG ;
Harris, RS ;
Neuberger, MS .
CURRENT BIOLOGY, 2003, 13 (22) :2009-2013
[8]   Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 [J].
Derdeyn, CA ;
Decker, JM ;
Sfakianos, JN ;
Wu, XY ;
O'Brien, WA ;
Ratner, L ;
Kappes, JC ;
Shaw, GM ;
Hunter, E .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8358-8367
[9]  
FOLEY GE, 1965, CANCER RES, V25, P1254
[10]   HIV-I Vif, APOBEC, and intrinsic immunity [J].
Goila-Gaur, Ritu ;
Strebel, Klaus .
RETROVIROLOGY, 2008, 5 (1)